Discontinuation report PANTO IV
Report ID | 2969 |
Drug Identification Number | 02239616 |
Brand name | PANTO IV |
Common or Proper name | Pantoprazole sodium |
Company Name | TAKEDA CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PANTOPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 vial x 10 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-03-13 |
Remaining supply date | 2017-03-13 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | There is no supply remaining. |
Company comments | Unanticipated depletion of remaining stock by wholesaler due to generic drug shortage. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-03-15 | French | Compare |
v1 | 2017-03-15 | English | Compare |
Showing 1 to 2 of 2